Messages are loaded...
Blood cancer affects tens of thousands of people in Germany. For many, a stem cell transplant is the last hope. But which preparation for this procedure helps the most, especially for older or previously ill patients? Researchers at Dresden University Hospital and Kiel University Hospital now want to find out in the largest German study of its kind.
Around one in three stroke patients suffers a relapse - often just a few days after the initial cerebral infarction. Doctors at TU Dresden are now starting a large nationwide study with 2,100 participants. They want to find out whether a combination of two drugs provides better protection against a second stroke than the current standard therapy. The Federal Ministry of Research is funding the project with three million euros.
How do cells talk to each other? A team at TU Dresden has succeeded in making the most important sensors on the cell surface visible for the first time. The so-called proteoglycans receive signals and control how cells grow and react. The new method could help to better understand cancer and develop new therapies in the future.
In future, nanoparticles will be used to distribute drugs in the body in a targeted manner. But how does the blood react to these tiny helpers? A study from Dresden shows that both the mass and number of particles are crucial.
Is it possible to find people more likeable through thought alone? Yes, say researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig. Their study shows: Imagination changes the brain in a similar way to real experiences. This opens up new opportunities for therapy and relationships.
Researchers at the Helmholtz-Zentrum Dresden-Rossendorf have developed a molecular marker to help doctors choose the right bladder cancer therapy. The radiotracer NECT-224 makes visible whether tumors carry a certain protein to which modern drugs can dock. In summer 2025, it was used successfully for the first time on a patient at Dresden University Hospital.
A research group at TU Dresden has decoded a central mechanism in cancer cells. This enables safer therapies.
Lois Openda from RB Leipzig uses colored glasses to keep him wide awake on the pitch. The speedy striker has another trick up his sleeve.